Blog

Oct 27, 2024

FDA curbs unfounded memory supplement claims - Harvard Health

Mind & Mood I must have seen the commercial for Prevagen 50 times. Perhaps you've seen it, too: "You might take something for your heart… your joints… your digestion. So why wouldn't you take

Mind & Mood

I must have seen the commercial for Prevagen 50 times. Perhaps you've seen it, too: "You might take something for your heart… your joints… your digestion. So why wouldn't you take something for the most important part of you… your brain? With an ingredient originally found in jellyfish! Healthier brain, better life!"

Like many heavily-advertised supplements, this one makes many claims. The bottle promises it "improves memory" and "supports: healthy brain function, sharper mind, clearer thinking." Never mind that the main ingredient in jellyfish (apoaequorin) has no known role in human memory, or that many experts believe supplements like this would most likely be digested in the stomach and never wind up anywhere near the brain. Oh, and the commercial doesn't mention any risks of treatment or cost (though I found it online for $1 to $2/day).

But does this supplement actually do what it says? If it doesn't, how can the manufacturer make these claims? And if apoaequorin is so great, why aren't jellyfish smarter, as a colleague of mine wonders?

As "proof" of power, a bar graph shows a rise from 5% to 10% to 20% over 90 days in "recall tasks." But there's no way to know what these numbers refer to, how many people were studied, or other important details. And no information is provided about effects on memory after 90 days. The fine print under the graph says that the supplement "improved recall tasks in subjects" without explaining what this means. While a small, company-sponsored study reported improvements in memory after people took apoaequorin, the published version demonstrated improvements only in a subset of study patients, and the impact of these changes were of uncertain impact. While the study's authors recommended additional study to clarify the effectiveness of apoaequorin, additional, high-quality studies have not been published.

The US Federal Trade Commission and the New York State Attorney General weren't convinced of the supplement's benefits. They charged the supplement maker with false advertising back in 2017; in February 2024, a New York jury found that many of the supplement's claims were not supported by reliable evidence and some (but not all) of the claims were "materially misleading." The FTC lawsuit has not yet been decided.

Although there are many thousands of supplements and hundreds of conditions for which they're intended, it's often hard to say if they're doing much of anything. For example, glucosamine has been promoted for many years as "good for joint health." I have patients who swear by it. But the best studies suggest modest effects, if any. When it comes to "heart healthy" vitamins, consider the example of vitamin E, once considered potentially useful to prevent or treat heart disease. Yet, study after study showed no benefit. In fact, it may increase the risk of heart failure. As for probiotic supplements, there is not yet convincing evidence that their use improves digestive health or prevents digestive disease in healthy people.

Rather than focus on the benefits touted, it may make more sense to read the standard disclaimer required on supplements: "These statements have not been evaluated by the FDA."

Fortunately, the FDA does take note of false claims that go too far. On Feb. 11, 2019, Scott Gottlieb, then the FDA commissioner, announced a plan to modernize regulation and oversight of dietary supplements. Key points include:

The FDA and FTC continue to provide oversight to the dietary supplement industry although it's a daunting task given the sheer volume of products on the market.

There is clearly an enormous appetite in this country for dietary supplements. The supplement industry is now worth an estimated $60 billion or more, with as many as 100,000 products available for purchase.

But there's a reason dietary supplements carry a disclaimer: "This product is not intended to diagnose, treat, cure, or prevent any disease." It should remind us all to be skeptical of claims we see in ads for dietary supplements. Unlike prescription drugs, supplements are not thoroughly tested or evaluated. While dietary supplements might provide benefits in certain cases, it's vitally important that their makers not make unfounded claims to exploit consumers. And, of course, these products should contain only what they're supposed to contain.

I think the FDA's plan to take strong action on dietary supplements is good news. I hope it leads to some real change in the industry. In the meantime, be skeptical about ads for products that seem too good to be true. There's a good chance they are.

Robert H. Shmerling, MD, Senior Faculty Editor, Harvard Health Publishing; Editorial Advisory Board Member, Harvard Health Publishing

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.